Hedayati recommends shared decision making and a 4 to 6 week treatment trial, stopping therapy when patients don’t respond.
Susan Hedayati, MD, MHSc
Advertisement
Susan Hedayati, MD, MHSc is the vice dean for research and professor of medicine in nephrology at Stony Brook University Renaissance School of Medicine.
Articles by Susan Hedayati, MD, MHSc
An early behavioral activation therapy signal at 8 weeks didn’t hold, and bupropion brought more insomnia and confusion.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
eGFR Underestimates CKD in Patients with Cancer, Study Finds
2
Inside The New AHA/ACC Acute Pulmonary Embolism Categories
3
Tradipitant Cuts Semaglutide-Induced Vomiting in Phase 3 Trial
4
Respiratory Monitoring After Spinal Muscular Atrophy Gene Therapy
5